Literature DB >> 23606365

The diagnosis, prevalence and outcome of delirium in a cohort of older people with mental health problems on general hospital wards.

Kathy H Whittamore1, Sarah E Goldberg, John R F Gladman, Lucy E Bradshaw, Rob G Jones, Rowan H Harwood.   

Abstract

OBJECTIVES: This paper aimed to measure the prevalence and outcomes of delirium for patients over 70 admitted to a general hospital for acute medical care and to assess the validity of the Delirium Rating Scale-Revised-98 (DRS-R-98) in this setting.
METHODS: Prospective study in a British acute general hospital providing sole emergency medical services for its locality. We screened consecutive patients over 70 with an unplanned emergency hospital admission and recruited a cohort of 249 patients likely to have mental health problems. They were assessed for health status at baseline and followed over 6 months. A sub-sample of 93 participants was assessed clinically for delirium.
RESULTS: 27% (95% confidence interval (CI) 23-31) of all older medical patients admitted to hospital had DRS-diagnosed delirium, and 41% (95% CI 37-45) had dementia (including 19% with co-morbid delirium and dementia). Compared with clinician diagnosis, DRS-R-98 sensitivity was at least 0.75, specificity 0.71. Compared with reversible cognitive impairment, sensitivity was at least 0.50, specificity 0.67. DRS-diagnosed delirium was associated with cognitive impairment, mood, behavioural and psychological symptoms, activities of daily living, and number of drugs prescribed, supporting construct validity. Of those with DRS-diagnosed delirium, 37% died within 6 months (relative risk 1.4, 95% CI 0.97-2.2), 43% had reversible cognitive impairment, but only 25% had clinically important recovery in activities of daily living. Behavioural and psychological symptoms were common and mostly resolved, but new symptoms frequently developed.
CONCLUSION: Delirium is common. Some, but not all, features are reversible. DRS-R-98 has reasonable validity in populations where co-morbid dementia is prevalent.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Delirium Rating Scale; delirium; diagnosis; general hospital; older person; prognosis; validity

Mesh:

Year:  2013        PMID: 23606365     DOI: 10.1002/gps.3961

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  22 in total

1.  The validation and inter-rater reliability of the Serbian translation of the Richmond agitation and sedation scale in post anesthesia care unit patients.

Authors:  Karlicic Stasevic; M Stasevic; S Jankovic; Dejanovic Djukic; A Dutina; I Grbic
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

Review 2.  Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.

Authors:  Shirley H Bush; Salmaan Kanji; José L Pereira; Daniel H J Davis; David C Currow; David Meagher; Kiran Rabheru; David Wright; Eduardo Bruera; Michael Hartwick; Pierre R Gagnon; Bruno Gagnon; William Breitbart; Laura Regnier; Peter G Lawlor
Journal:  J Pain Symptom Manage       Date:  2014-01-28       Impact factor: 3.612

Review 3.  Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.

Authors:  Jennifer K Burton; Louise Craig; Shun Qi Yong; Najma Siddiqi; Elizabeth A Teale; Rebecca Woodhouse; Amanda J Barugh; Alison M Shepherd; Alan Brunton; Suzanne C Freeman; Alex J Sutton; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2021-11-26

4.  An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives.

Authors:  Peter G Lawlor; Daniel H J Davis; Mohammed Ansari; Annmarie Hosie; Salmaan Kanji; Franco Momoli; Shirley H Bush; Sharon Watanabe; David C Currow; Bruno Gagnon; Meera Agar; Eduardo Bruera; David J Meagher; Sophia E J A de Rooij; Dimitrios Adamis; Augusto Caraceni; Katie Marchington; David J Stewart
Journal:  J Pain Symptom Manage       Date:  2014-04-12       Impact factor: 3.612

5.  Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.

Authors:  Jennifer K Burton; Louise E Craig; Shun Qi Yong; Najma Siddiqi; Elizabeth A Teale; Rebecca Woodhouse; Amanda J Barugh; Alison M Shepherd; Alan Brunton; Suzanne C Freeman; Alex J Sutton; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2021-07-19

6.  Delivering dementia care differently--evaluating the differences and similarities between a specialist medical and mental health unit and standard acute care wards: a qualitative study of family carers' perceptions of quality of care.

Authors:  Karen Spencer; Pippa Foster; Kathy H Whittamore; Sarah E Goldberg; Rowan H Harwood
Journal:  BMJ Open       Date:  2013-12-20       Impact factor: 2.692

Review 7.  Delirium diagnosis, screening and management.

Authors:  Peter G Lawlor; Shirley H Bush
Journal:  Curr Opin Support Palliat Care       Date:  2014-09       Impact factor: 2.302

8.  Delirium risk stratification in consecutive unselected admissions to acute medicine: validation of externally derived risk scores.

Authors:  Sarah T Pendlebury; Nicola Lovett; Sarah C Smith; Emily Cornish; Ziyah Mehta; Peter M Rothwell
Journal:  Age Ageing       Date:  2016-01       Impact factor: 10.668

9.  Observational, longitudinal study of delirium in consecutive unselected acute medical admissions: age-specific rates and associated factors, mortality and re-admission.

Authors:  S T Pendlebury; N G Lovett; S C Smith; N Dutta; C Bendon; A Lloyd-Lavery; Z Mehta; P M Rothwell
Journal:  BMJ Open       Date:  2015-11-16       Impact factor: 2.692

10.  Diagnoses, problems and healthcare interventions amongst older people with an unscheduled hospital admission who have concurrent mental health problems: a prevalence study.

Authors:  Alex Glover; Lucy E Bradshaw; Nicola Watson; Emily Laithwaite; Sarah E Goldberg; Kathy H Whittamore; Rowan H Harwood
Journal:  BMC Geriatr       Date:  2014-04-02       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.